Editorial: Sleep apnoea and malignant ventricular arrhythmias in heart failure

European Heart Journal

Volumn 32, Issue 1, 2011, Pages 10-12

  Floras, John ^a   Andreas, Stefan ^b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NORADRENALIN;

AIRWAY PRESSURE; APNEA HYPOPNEA INDEX; BLOOD PRESSURE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR RISK; CHEYNE STOKES BREATHING; CONGESTIVE HEART FAILURE; DEFIBRILLATOR; DISEASE SEVERITY; EDITORIAL; EVENT FREE SURVIVAL; HEART EJECTION FRACTION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; MALIGNANT VENTRICULAR ARRHYTHMIA; NORADRENALIN RELEASE; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SLEEP APNEA SYNDROME; SUDDEN DEATH; SYMPATHETIC NERVE; AGED; HEART ARRHYTHMIA; HEART FAILURE; NOTE; RISK FACTOR;

AGED; AGED, 80 AND OVER; ARRHYTHMIAS, CARDIAC; HEART FAILURE; HUMANS; RISK FACTORS; SLEEP APNEA SYNDROMES;

EID: 78651286666     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehq338     Document Type: Editorial

References (18)

1. Schulz R, Blau A, Borgel J, Duchna HW, Fietze I, Koper I, Prenzel R, Schadlich S, Schmitt J, Tasci S, Andreas S. Sleep apnoea in heart failure - results of a German survey. Eur Respir J 2007;29:1201-1205.
2. Wang H, Parker JD, Newton GE, Floras JS, Mak S, Chiu KL, Ruttanaumpawan P, Tomlinson G, Bradley TD. Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol 2007;49:1625-1631.
3. Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995;96:1897-1904.
4. Spicuzza L, Bernardi L, Calciati A, Di Maria GU. Autonomic modulation of heart rate during obstructive versus central apneas in patients with sleep-disorDered breathing. Am J Resp Crit Care Med 2003;167:902-910.
5. Andreas S, Eichele G. Sleep apnea - time to consiDer clock genes. Eur Respir J 2008;32:1-2.
6. Spaak J, Egri ZJ, Kubo T, Yu E, Ando S, Kaneko Y, Usui K, Bradley TD, Floras JS. Muscle sympathetic nerve activity during wakefulness in heart failure patients with and without sleep apnea. Hypertension 2005;46:1327-1332.
7. Floras JS. Sympathetic nervous system activation in human heart failure: clinical implications of an updated model. J Am Coll Cardiol 2009;54:375-385.
8. Mansfield D, Kaye DM, Brunner La Rocca H, Solin P, Esler MD, Naughton MT. Raised sympathetic nerve activity in heart failure and central sleep apnea is due to heart failure severity. Circulation 2003;107:1396-1400.
9. Meredith IT, Broughton A, Jennings GL, Esler MD. Evidence of a selective increase in cardiac sympathetic activity in patients with sustained ventricular arrhythmias. N Engl J Med 1991;325:618-624.
10. Wilbert-Lampen U, Leistner D, Greven S, Pohl T, Sper S, Volker C, Guthlin D, Plasse A, Knez A, Kuchenhoff H, Steinbeck G. Cardiovascular events during World Cup soccer. N Engl J Med 2008;358:475-483.
11. Findley LJ, Blackburn MR, Goldberger AL, Mandell AJ. Apneas and oscillation of cardiac ectopyinCheyne-Stokes breathing during sleep.AmRev Respir Dis 1984;130:937-939.
12. Lanfranchi PA, Somers VK, Braghiroli A, Corra U, Eleuteri E, Giannuzzi P. Central sleep apnea in left ventricular dysfunction: prevalence and implications for arrhythmic risk. Circulation 2003;107:727-732.
13. Serizawa N, Yumino D, Kajimoto K, Tagawa Y, Takagi A, Shoda M, Kasanuki H, Hagiwara N. Impact of sleep-disorDered breathing on life-threatening ventricular arrhythmia in heart failure patients with implantable cardioverter-defibrillator. Am J Cardiol 2008;102:1064-1068.
14. Bitter T, Westerheide N, Prinz C, Hossain SM, Vogt J, Langer C, Horstkotte D, Oldenburg O. Cheyne-Stokes respiration and obstructive sleep apnoea are independent risk factors for malignant ventricular arrhythmias requiring appropriate cardioverter-defibrillator therapies in patients with congestive heart failure. Eur Heart J 2011;32:61-74. First published on 16 September 2010. doi:10.1093/eurheartj/ehq327.
15. Bradley TD, Floras JS. Obstructive sleep apnoea and its cardiovascular consequences. Lancet 2009;373:82-93.
16. Usui K, Bradley TD, Spaak J, Ryan CM, Kubo T, Kaneko Y, Floras JS. Inhibition of awake sympathetic nerve activity of heart failure patients with obstructive sleep apnea by nocturnal continuous positive airway pressure. J Am Coll Cardiol 2005; 45:2008-2011. (Pubitemid 40814123)
17. Ryan CM, Usui K, Floras JS, Bradley TD. Effect of continuous positive airway pressure on ventricular ectopy in heart failure patients with obstructive sleep apnoea. Thorax 2005;60:781-785. (Pubitemid 41297899)
18. Bradley TD, Logan AG, Kimoff RJ, Series F, Morrison D, Ferguson K, Belenkie I, Pfeifer M, Fleetham J, Hanly P, Smilovitch M, Tomlinson G, Floras JS. Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med 2005;353:2025-2033.